[ad_1] Nine of 11 people living with HIV maintained a "beautiful and long-lasting" viral suppression after receiving two highly neutralizing antibodies (BNAbs) against HIV, almost tripling the average viral rebound observed in …
Read More »Combination of antibodies can control HIV without daily pills
[ad_1] WEDNESDAY, September 26, 2018 – A combination of two anti-HIV antibodies may suppress the virus in some patients, even after stopping standard drugs, showed a preliminary test. The researchers found that …
Read More »New therapy could control HIV without daily pills
[ad_1] So they tested a combination of two bNAbs among people qualified as "elite controllers". They have HIV, but their immune system is able to control the virus without drugs. In one …
Read More »In clinical trials, new antibody therapy controls HIV for months after treatment
[ad_1] Marina Caskey, a researcher who is part of a new clinical trial that shows that largely neutralizing antibodies can suppress HIV up to four months, much longer than currently available drugs. …
Read More »New therapy could control HIV without daily pills
[ad_1] WEDNESDAY, Sept. 26, 2018 (HealthDay News) – A combination of two anti-HIV antibodies can suppress the virus in some patients, even after stopping standard drugs, showed a preliminary test. The researchers …
Read More »Strong antibodies suppress HIV for months, could simplify treatment | Science
[ad_1] New studies have shown that strong (blue and green) antibody infusions on HIV surface protein (red) help control infection for months. Donald Bliss and Sriram Subramaniam / NIH By Jon CohenSept. …
Read More »HIV Immunotherapy Study with Proof of Concept Passes Phase 1 Safety Trial – ScienceDaily
[ad_1] Preliminary results from a Phase I clinical trial demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion in individuals …
Read More »T-cell therapy to eradicate HIV reservoirs proves safe in a small study
[ad_1] Antiretroviral drugs have revolutionized the treatment of HIV, the virus that causes AIDS, but they are not considered a cure. This is because HIV can hide in the body in "reservoirs" …
Read More »An HIV immunotherapy study with proof of concept passes the Phase 1 safety trial
[ad_1] HIV infecting a human cell. Credit: NIH Preliminary results from a Phase I clinical trial demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T …
Read More »Experts to spread HIV awareness | Guwahati News
[ad_1] GUWAHATI: The state government has experts from the Department of Health and Education to educate young people about responsible and safe sexual behavior to control the spread of HIV. India HIV …
Read More »